about
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the fiel...
Read More
58.50
2.88
(5.18%)
1.1M
XNAS Volume
XNAS 26 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..